Vanguard Group’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-835,120
| Closed | -$19.3M | – | 4371 |
|
|
2020
Q4 | $19.3M | Buy |
835,120
+69,274
| +9% | +$1.6M | ﹤0.01% | 2648 |
|
|
2020
Q3 | $7.8M | Buy |
765,846
+36,952
| +5% | +$376K | ﹤0.01% | 2914 |
|
|
2020
Q2 | $10.9M | Buy |
728,894
+364,402
| +100% | +$5.43M | ﹤0.01% | 2729 |
|
|
2020
Q1 | $4.44M | Buy |
364,492
+58,602
| +19% | +$714K | ﹤0.01% | 3017 |
|
|
2019
Q4 | $4.84M | Buy |
305,890
+71,431
| +30% | +$1.13M | ﹤0.01% | 3185 |
|
|
2019
Q3 | $2.88M | Buy |
234,459
+157,556
| +205% | +$1.93M | ﹤0.01% | 3324 |
|
|
2019
Q2 | $1.02M | Buy |
+76,903
| New | +$1.02M | ﹤0.01% | 3675 |
|